New Oncology Nursing Society Guidelines for Chemotherapy and Immunotherapy
Posted by donna@healthlawcenterplc.com in Jun, 2018
With the explosion of immunotherapy and rapid changes in oncology treatment guidelines, it is all nurses can do to stay abreast of best practices. The Oncology Nursing Society (ONS) will soon fill this growing educational gap with a complete update of Chemotherapy and Biotherapy Guidelines and Recommendations for Practice, a classic foundational volume now in its fourth edition. This fall, the ONS will publish the revamped and renamed volume as the first edition of the Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice.
The reorganized book includes a new chapter that focuses on the treatment of cancer using the immune system, immunotherapeutics. The chapter presents 6 categories of this approach: checkpoint inhibitors; chimeric antigen receptor (CAR) T-cell immunotherapy; cytokines; monoclonal antibodies, including radioimmunotherapy; immunomodulators; and oncolytic viral therapy.
Other chapters focus on chemotherapy, molecularly targeted anticancer agents, and hormonal therapy, with updates on unique toxicities such as colitis, pneumonitis, and dermatitis.
Category: News & Updates, Nursing, Professional Development
Post Tagged with 
